Cargando…
Low LDL-C level and intracranial haemorrhage risk after ischaemic stroke: a prospective cohort study
BACKGROUND AND PURPOSE: The Treat Stroke to Target trial has confirmed the benefit of targeting low-density lipoprotein cholesterol (LDL-C) of <1.8 mmol/L in patients who had an ischaemic stroke (IS). However, haemorrhagic risk brought by this target level (<1.8 mmol/L) or even lower level (&l...
Autores principales: | Xu, Jie, Chen, Zimo, Wang, Meng, Mo, Jinglin, Jing, Jing, Yalkun, Gulbahram, Dai, Liye, Meng, Xia, Li, Hao, Li, Zixiao, Wang, Yongjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176994/ https://www.ncbi.nlm.nih.gov/pubmed/36162902 http://dx.doi.org/10.1136/svn-2022-001612 |
Ejemplares similares
-
Effect of Low Diastolic Blood Pressure to Cardiovascular Risk in Patients With Ischemic Stroke or Transient Ischemic Attacks Under Different Systolic Blood Pressure Levels
por: Chen, Zimo, et al.
Publicado: (2020) -
Cumulative burden of lipid profiles predict future incidence of ischaemic stroke and residual risk
por: Dai, Liye, et al.
Publicado: (2021) -
The impact of the cumulative burden of LDL-c and hs-CRP on cardiovascular risk: a prospective, population-based study
por: Mo, Jinglin, et al.
Publicado: (2020) -
Concurrent intracranial and extracranial artery stenosis and the prognosis of transient ischaemic symptoms or imaging-negative ischaemic stroke
por: Suo, Yue, et al.
Publicado: (2020) -
LDL-C levels, lipid-lowering treatment and recurrent stroke in minor ischaemic stroke or TIA
por: Pan, Yuesong, et al.
Publicado: (2022)